These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2975225)

  • 41. Physiological effects of selective 5-HT1a and 5-HT1b ligands in rat hippocampus: comparison to 5-HT.
    Segal M; Azmitia EC; Whitaker-Azmitia PM
    Brain Res; 1989 Nov; 502(1):67-74. PubMed ID: 2531014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modification of sexual behavior of Long-Evans male rats by drugs acting on the 5-HT1A receptor.
    Rehman J; Kaynan A; Christ G; Valcic M; Maayani S; Melman A
    Brain Res; 1999 Mar; 821(2):414-25. PubMed ID: 10064829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serotonin agonists inhibit synaptic potentials in the rat locus ceruleus in vitro via 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptors.
    Bobker DH; Williams JT
    J Pharmacol Exp Ther; 1989 Jul; 250(1):37-43. PubMed ID: 2526217
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determination of the 5-HT receptor subtype involved in 8-OH-DPAT-induced hyperlocomotion: potential difficulties arising from inadequate pharmacological tools.
    Kalkman HO; Soar J
    Eur J Pharmacol; 1990 Dec; 191(3):383-90. PubMed ID: 2150821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Behavioral and neurochemical effects of the serotonin (5-HT)1A receptor ligand spiroxatrine.
    Barrett JE; Hoffmann SM; Olmstead SN; Foust MJ; Harrod C; Weissman BA
    Psychopharmacology (Berl); 1989; 97(3):319-25. PubMed ID: 2524083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The involvement of 5-hydroxytryptaminergic and dopaminergic mechanisms in the eating induced by buspirone, gepirone and ipsapirone.
    Fletcher PJ; Davies M
    Br J Pharmacol; 1990 Mar; 99(3):519-25. PubMed ID: 2139586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of 5-HT1A receptor agonists on the circadian rhythm of wheel-running activity in hamsters.
    Tominaga K; Shibata S; Ueki S; Watanabe S
    Eur J Pharmacol; 1992 Apr; 214(1):79-84. PubMed ID: 1316283
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Opposite control mediated by central 5-HT1A and non-5-HT1A (5-HT1B or 5-HT1C) receptors on periaqueductal gray aversion.
    Jenck F; Broekkamp CL; Van Delft AM
    Eur J Pharmacol; 1989 Feb; 161(2-3):219-21. PubMed ID: 2524392
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of neuronal activity in the hippocampus by 5-hydroxytryptamine and 5-hydroxytryptamine1A selective drugs.
    Peroutka SJ; Mauk MD; Kocsis JD
    Neuropharmacology; 1987; 26(2-3):139-46. PubMed ID: 2884586
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Three putative 5-HT1A agonists act as 5-HT antagonists in frog sensory neurons.
    Marszalec W; Anderson EG
    Eur J Pharmacol; 1988 Sep; 154(3):325-8. PubMed ID: 2976672
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors.
    Peroutka SJ
    Biol Psychiatry; 1985 Sep; 20(9):971-9. PubMed ID: 2862927
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Benzodiazepines and putative 5-HT1A agonists increase hypertonic saline consumption in rehydrating rats.
    Cooper SJ; Desa A
    Pharmacol Biochem Behav; 1987 Oct; 28(2):187-91. PubMed ID: 2825218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of intraventricular administration of eltoprazine, 1-(3-trifluoromethylphenyl)piperazine hydrochloride and 8-hydroxy-2-(di-n-propylamino)tetralin on resident intruder aggression in the rat.
    Mos J; Olivier B; Poth M; van Aken H
    Eur J Pharmacol; 1992 Mar; 212(2-3):295-8. PubMed ID: 1534769
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis.
    Sharp T; Bramwell SR; Grahame-Smith DG
    Br J Pharmacol; 1989 Feb; 96(2):283-90. PubMed ID: 2466516
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
    Yocca FD; Iben L; Meller E
    Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptors.
    Hutson PH; Dourish CT; Curzon G
    Eur J Pharmacol; 1988 Jun; 150(3):361-6. PubMed ID: 2970974
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Engel JA; Hjorth S; Svensson K; Carlsson A; Liljequist S
    Eur J Pharmacol; 1984 Oct; 105(3-4):365-8. PubMed ID: 6239785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanisms of serotonergic affect control.
    Kennett GA
    Adv Exp Med Biol; 1991; 294():231-43. PubMed ID: 1685293
    [No Abstract]   [Full Text] [Related]  

  • 59. 1-(2-pyrimidinyl)-piperazine may alter the effects of the 5-HT1A agonist in the learned helplessness paradigm in rats.
    Martin P
    Psychopharmacology (Berl); 1991; 104(2):275-8. PubMed ID: 1678895
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat.
    Dreteler GH; Wouters W; Saxena PR
    Eur J Pharmacol; 1990 May; 180(2-3):339-49. PubMed ID: 2142096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.